COMMUNIQUÉS West-GlobeNewswire

MediWound to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 13

06/08/2019 - 14:00

YAVNE, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Immutep Completes A$6M Entitlement Offer

06/08/2019 - 14:00

SYDNEY, Australia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”) is pleased to announce the completion of its fully underwritten pro rata non-renounceable [...]

Seoul National University Hospital and Syapse Sign Multi-Year Renewal Agreement to Expand Access to Precision Medicine in South Korea

06/08/2019 - 14:00

Syapse and SNUH will work together to build Asia’s first learning health network of real-world data derived from the region’s leading precision oncology hospitals Co-hosted symposium of East Asian hospitals will share [...]

Avricore Health Welcomes Kiki Smith as Chief Financial Officer

06/08/2019 - 14:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]

Arbutus to Participate at Wedbush PacGrow Healthcare Conference

06/08/2019 - 13:30

WARMINSTER, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia will [...]

Kiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare Conference

06/08/2019 - 13:30

HAMILTON, Bermuda, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa, will present at the [...]

XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results

06/08/2019 - 13:30

Novartis’s iscalimab highlighted at key scientific conferences First patient dosed with gevokizumab in collaborator clinical study Sesen Bio announced intention to initiate Vicinium® BLA filing process in 2019 Royalty [...]

Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer

06/08/2019 - 13:30

Commercial build-out to support anticipated launch of suvodirsen and other future commercialized products CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage [...]

T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS

06/08/2019 - 13:30

Designation granted only to new technologies that demonstrate substantial clinical improvement LEXINGTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development [...]

Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS®

06/08/2019 - 13:30

NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]

Neuronetics Reports Second Quarter 2019 Financial and Operating Results

06/08/2019 - 13:30

MALVERN, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]

Kamada Reports Financial Results for Second Quarter and First Six Months of 2019

06/08/2019 - 13:15

Total Revenues for Second Quarter of 2019 were $35.3 Million, a 4% Increase Year-Over-Year Total Revenues for First Six Months of 2019 were $62.1 Million, a 21% Increase Year-Over-Year Gross Profit for Second Quarter [...]

BioCryst Reports Second Quarter 2019 Financial Results

06/08/2019 - 13:15

—New drug application for once-daily oral BCX7353 for prophylaxis of hereditary angioedema attacks on-track for submission in Q4 2019— —Data from ongoing Phase 1 trial of oral Factor D inhibitor, BCX9930, expected in Q4 [...]

Indus Holdings, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference

06/08/2019 - 13:12

SALINAS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that Co-founder and Chief Executive Officer Robert Weakley [...]

Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial

06/08/2019 - 13:01

-EDP1815 was Well Tolerated with No Overall Difference Reported from Placebo- -Patients Dosed with EDP1815 Showed a Reduction in Mean Lesion Severity Score vs. Placebo- -Reductions Observed in Cellular Histological and [...]

Orchard Therapeutics to Webcast Presentation at the 2019 Wedbush PacGrow Healthcare Conference

06/08/2019 - 13:00

BOSTON and LONDON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]

G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August

06/08/2019 - 13:00

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will participate in two investor conferences in [...]

Nabriva Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

06/08/2019 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]

GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute

06/08/2019 - 13:00

Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines LONDON and WASHINGTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- GSK and the Sabin Vaccine Institute (Sabin) today [...]